Clinical Trial Update: Combination of Halobetasol Propionate and Tazarotene Lotion (Duobrii®) for Palmoplantar Plaque Type Psoriasis [Phase 4]

View source ↗

Summary

Phase 4 trial update on the combination of halobetasol propionate and tazarotene lotion (Duobrii) for palmoplantar plaque-type psoriasis, with completed status …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Palmoplantar Psoriasis
• Plaque Psoriasis

Drugs mentioned

• Duobrii (halobetasol propionate and tazarotene)

Snippet

Sponsor: Icahn School of Medicine at Mount Sinai | Conditions: Palmoplantar Psoriasis, Plaque Psoriasis | Phase 4 | Status: COMPLETED | Results posted: 2023-10-27